glp 1 sglt2 3. Integration of GLP-1RA or SGLT2i in Patients With T2D With or at Risk of atherosclerotic CVD SGLT2i and GLP-1 RA therapy

Loomba R, Hartman M L, Lawitz E J, et al

Sometimes GLP-1s that are approved for type 2 diabetes can be prescribed off-label for weight loss

From bench to bedside

10.1097/00001756-199906030-00004 Neuroreport 53 OngZ

#ProactiveCarePartners, #ProactiveCare, #PrimaryCare, #WholePersonCare, #PreventiveCare, #BenefitsStrategy, #EmployeeBenefits, #EmployeeWellness, #HealthcareStrategy, #HealthBenefits, #HealthBenefitsStrategy, #HealthPlanDesign, #ValueBasedCare, #CorporateWellness, #PopulationHealth, #DataDrivenCare, #PublicHealth, #ChronicDiseaseManagement, #HealthPolicy, #LifestyleMedicine, #HealthcareReform, #GLP1, #PharmacySpend, #ROI GLP-1 RAs and Prior Major Adverse Limb Events in Patients With Diabetes jamanetwork.com To view or add a comment, sign in We call for a shift away from Kt/V-centric quality frameworks and the concept of adequate dialysis, advocating instead for a more holistic model of high-quality, person-centered dialysis care